Chemistry:XAP044
From HandWiki
Short description: Chemical compound
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
Chemical and physical data | |
Formula | C15H9IO4 |
Molar mass | 380.137 g·mol−1 |
3D model (JSmol) | |
| |
|
XAP044 is a drug which acts as a potent and selective antagonist of the metabotropic glutamate receptor 7 (mGluR7). It inhibits long-term potentiation in the amygdala and inhibits responses associated with stress and anxiety in animal models,[1] as well as being used to study the role of mGluR7 in various other processes.[2][3][4]
References
- ↑ "Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior". The Journal of Biological Chemistry 289 (16): 10975–10987. April 2014. doi:10.1074/jbc.M113.542654. PMID 24596089.
- ↑ "Role of mGlu7 receptor in morphine rewarding effects is uncovered by a novel orthosteric agonist". Neuropharmacology 131: 424–430. March 2018. doi:10.1016/j.neuropharm.2018.01.002. PMID 29307544.
- ↑ "Metabotropic glutamate receptor subtype 7 controls maternal care, maternal motivation and maternal aggression in mice". Genes, Brain and Behavior 19 (1): e12627. January 2020. doi:10.1111/gbb.12627. PMID 31793148.
- ↑ "Blocking Metabotropic Glutamate Receptor Subtype 7 via the Venus Flytrap Domain Promotes a Chronic Stress-Resilient Phenotype in Mice". Cells 11 (11): 1817. June 2022. doi:10.3390/cells11111817. PMID 35681512.
Original source: https://en.wikipedia.org/wiki/XAP044.
Read more |